Showing results (1231-1240 of 1,402) with videos related to
Sort By:
Pageof 141
Transactions of the Royal Society of Tropical Medicine and Hygiene|October 10, 2006
Age-related changes in hookworm infection, anaemia and iron deficiency in an area of high Necator americanus hookworm transmission in south-eastern BrazilSimon Brooker, Anne Jardim-Botelho, Rupert J Quinnell, et al.Marine Environmental Research|August 21, 2021
Effects of COVID-19 pandemic restrictions on coral reef fishes at eco-tourism sites in Bora-Bora, French PolynesiaDavid Lecchini, Rohan M Brooker, Viliame Waqalevu, et al.Bioorganic & Medicinal Chemistry Letters|August 29, 2007
Synthesis and SAR of 2-aryl pyrido[2,3-d]pyrimidines as potent mGlu5 receptor antagonistsJohn A Wendt, Susan D Deeter, Susan E Bove, et al.Annals of Work Exposures and Health|May 14, 2026
Reliability of self-reported career histories reported by former professional association football players included in the health and ageing data iN the game of football (HEADING) studyIoannis Basinas, Helena Copsey, Fiona S Carson, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 15, 2014
An observational study of matrix metalloproteinase (MMP)-9 in cystic fibrosisGraham Devereux, Sandra Steele, Timothy Jagelman, et al.Crisis|November 13, 2025
Hospital Outreach Postsuicide Attempt Engagement (HOPE)Stanley Innes, Charlie Palmer, Elle Nguyen, et al.Nature Communications|October 19, 2016
A pulse of mid-Pleistocene rift volcanism in Ethiopia at the dawn of modern humansWilliam Hutchison, Raffaella Fusillo, David M Pyle, et al.Biochemical and Biophysical Research Communications|February 15, 1988
(+/-)-trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonistM M Ponpipom, S B Hwang, T W Doebber, et al.Radiology|June 1, 1987
Volumetric rendering techniques: applications for three-dimensional imaging of the hipE K Fishman, B Drebin, D Magid, et al.Pain Practice : the Official Journal of World Institute of Pain|March 26, 2021
ECAP-Controlled Closed-Loop Spinal Cord Stimulation Efficacy and Opioid Reduction Over 24-Months: Final Results of the Prospective, Multicenter, Open-Label Avalon StudyCharles Brooker, Marc Russo, Michael J Cousins, et al.Pageof 141